Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 11 September, 2019

Northern Trust Corp

Form 8.3 - ABBVIE INC

RNS Number : 0100M
Northern Trust Corporation
11 September 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

 Northern Trust Corporation

Company dealt in

 AbbVie Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

 Common Stock USD 0.01

Date of dealing

 10th  September  2019

 

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


Long

Short


Number


(%)

Number


(%)

(1) Relevant securities

 21,096,740   1.43%


(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total

 21,096,740   1.43%


 

* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 92 securities into the relevant accounts and 2084 securities out of the relevant accounts.

 

 

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short


Number


(%)

Number


(%)

(1) Relevant securities



 

(2) Derivatives (other than options)



 

(3) Options and agreements to purchase/sell



Total




Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit ($)

BUY

414

66.2906

SELL

33

67.7146

SELL

6

67.7146

BUY

175

67.78

BUY

1997

66.3497

SELL

32

68.18

BUY

380

67.6998

SELL

15

67.67

SELL

67

67.7146

BUY

15

67.76

BUY

53

67.76

BUY

28

68.18

BUY

143

67.68

BUY

5

67.6998

BUY

82

67.6998

BUY

57

68.18

BUY

84

67.6998

SELL

10

67.7146

BUY

10

67.6998

BUY

22

67.6998

BUY

15

68.18

SELL

70

67.77

BUY

5

67.6998

BUY

5

67.6998

BUY

5

67.6998

BUY

211

67.6998

SELL

24

67.7146

BUY

81

67.6998

BUY

17

67.37

BUY

18

67.37

BUY

15

67.37

BUY

4

67.37

BUY

284

67.6998

BUY

75

67.6998

BUY

78

67.6998

BUY

21

68.18

SELL

14

67.7146

BUY

51

67.6998

BUY

49

68.18

BUY

60

67.6998

BUY

39

67.76

BUY

160

67.6998

SELL

23

67.7146

BUY

135

67.6998

SELL

24

67.7146

SELL

47

67.7521

SELL

105

67.7521

SELL

20

67.7146

BUY

125

67.6998

BUY

120

67.6998

SELL

18

67.7521

BUY

95

68.18

SELL

4

67.7146

BUY

264

67.68

SELL

2071

66.5405

BUY

25

67.6998

BUY

112

67.4

BUY

58

67.66

BUY

9

67.6998

BUY

41

67.6998

BUY

350

67.6998

BUY

75

67.6998

SELL

16

68.18

BUY

44

67.6998

BUY

12

67.6998

BUY

132

67.6998

BUY

44

67.6998

BUY

21

68.18

SELL

10

68.18

BUY

385

67.68

BUY

250

67.6998

SELL

75

66.235

BUY

62

67.6998

SELL

38

67.7146

BUY

47

67.6998

BUY

250

67.73

BUY

100

67.63

SELL

15

67.67

BUY

50

67.62

BUY

75

67.85

BUY

325

67.85

SELL

102

67.705

SELL

100

67.58

BUY

8

67.18

BUY

4

67.35

BUY

31

67.35

BUY

22

67.35

BUY

6

67.37

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)





 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)








 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)




 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)





Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            NO

 

Date of disclosure

 11th  September 2019

Contact name

Luke Piscina

Telephone number

0207 982 3697

If a connected EFM, name of offeree/offeror with which connected

 

 

If a connected EFM, state nature of connection (Note 10)


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISELBMJTMBBBBAL

a d v e r t i s e m e n t